APO Research
Talk to an analyst

APO RESEARCH · REPORT

Estrogen and Progesterone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Estrogen and Progesterone Industry Growth and Trends Forecast to 2032

19 December 2025118 pages

Choose your research edition.

Industry ResearchEstrogen and Progesterone Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Estrogen and Progesterone Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Estrogen and Progesterone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Estrogen and Progesterone Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Estrogen and Progesterone Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Estrogen and Progesterone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Estrogen and Progesterone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Estrogen and Progesterone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Estrogen and Progesterone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Estrogen and Progesterone include Aspen Pharmacare, Besins Healthcare, Dr.Kade Pharmazeutische Fabrik, F.I.S.-FABBRICA, Gedeon Richter, Jenapharm, MERCK SERONO, N.V.Organon and Novartis Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Estrogen and Progesterone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Estrogen and Progesterone market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Estrogen and Progesterone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Estrogen and Progesterone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Estrogen and Progesterone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Estrogen and Progesterone Market by Company

Aspen Pharmacare

Besins Healthcare

Dr.Kade Pharmazeutische Fabrik

F.I.S.-FABBRICA

Gedeon Richter

Jenapharm

MERCK SERONO

N.V.Organon

Novartis Pharma

Orion

Pfizer Healthcare

Teva Pharma

AstraZeneca

Bayer

Eli Lilly

Novo Nordisk

Abbott

Estrogen and Progesterone Segment by Type

Estrogen

Progesterone

Estrogen and Progesterone Segment by Application

Hospital

Pharmacy

Department of Endocrinology

Estrogen and Progesterone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Estrogen and Progesterone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Estrogen and Progesterone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Estrogen and Progesterone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Estrogen and Progesterone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Estrogen and Progesterone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Estrogen Table 2. Major Company of Progesterone Table 3. Global Estrogen and Progesterone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Estrogen and Progesterone Sales by Type (2021-2026) & (K Units) Table 5. Global Estrogen and Progesterone Sales Market Share in Volume by Type (2021-2026) Table 6. Global Estrogen and Progesterone Sales by Type (2021-2026) & (US$ Million) Table 7. Global Estrogen and Progesterone Sales Market Share in Value by Type (2021-2026) Table 8. Global Estrogen and Progesterone Price by Type (2021-2026) & (US$/Unit) Table 9. Global Estrogen and Progesterone Sales by Type (2027-2032) & (K Units) Table 10. Global Estrogen and Progesterone Sales Market Share in Volume by Type (2027-2032) Table 11. Global Estrogen and Progesterone Sales by Type (2027-2032) & (US$ Million) Table 12. Global Estrogen and Progesterone Sales Market Share in Value by Type (2027-2032) Table 13. Global Estrogen and Progesterone Price by Type (2027-2032) & (US$/Unit) Table 14. North America Estrogen and Progesterone Sales by Type (2021-2026) & (K Units) Table 15. North America Estrogen and Progesterone Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Estrogen and Progesterone Sales by Type (2021-2026) & (K Units) Table 17. Europe Estrogen and Progesterone Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Estrogen and Progesterone Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Estrogen and Progesterone Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Estrogen and Progesterone Sales by Type (2021-2026) & (K Units) Table 21. Latin America Estrogen and Progesterone Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Estrogen and Progesterone Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Estrogen and Progesterone Sales by Type (2021-2026) & (US$ Million) Table 24. Estrogen and Progesterone Industry Trends Table 25. Estrogen and Progesterone Industry Drivers Table 26. Estrogen and Progesterone Industry Opportunities and Challenges Table 27. Estrogen and Progesterone Industry Restraints Table 28. Global Estrogen and Progesterone Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Estrogen and Progesterone Revenue Market Share by Company (2021-2026) Table 30. Global Estrogen and Progesterone Sales by Company (2021-2026) & (K Units) Table 31. Global Estrogen and Progesterone Sales Share by Company (2021-2026) Table 32. Global Estrogen and Progesterone Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Estrogen and Progesterone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Estrogen and Progesterone Major Company Production Sites and Headquarters Table 35. Global Estrogen and Progesterone Company, Product Type & Application Table 36. Global Estrogen and Progesterone Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Estrogen and Progesterone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Estrogen and Progesterone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Estrogen and Progesterone Sales by Region (2021-2026) & (K Units) Table 41. Global Estrogen and Progesterone Sales Market Share in Volume by Region (2021-2026) Table 42. Global Estrogen and Progesterone Sales by Region (2021-2026) & (US$ Million) Table 43. Global Estrogen and Progesterone Sales Market Share in Value by Region (2021-2026) Table 44. Global Estrogen and Progesterone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Estrogen and Progesterone Sales by Region (2027-2032) & (K Units) Table 46. Global Estrogen and Progesterone Sales Market Share in Volume by Region (2027-2032) Table 47. Global Estrogen and Progesterone Sales by Region (2027-2032) & (US$ Million) Table 48. Global Estrogen and Progesterone Sales Market Share in Value by Region (2027-2032) Table 49. Global Estrogen and Progesterone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Estrogen and Progesterone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Estrogen and Progesterone Sales by Application (2021-2026) & (K Units) Table 52. Global Estrogen and Progesterone Sales Market Share in Volume by Application (2021-2026) Table 53. Global Estrogen and Progesterone Sales by Application (2021-2026) & (US$ Million) Table 54. Global Estrogen and Progesterone Sales Market Share in Value by Application (2021-2026) Table 55. Global Estrogen and Progesterone Price by Application (2021-2026) & (US$/Unit) Table 56. Global Estrogen and Progesterone Sales by Application (2027-2032) & (K Units) Table 57. Global Estrogen and Progesterone Sales Market Share in Volume by Application (2027-2032) Table 58. Global Estrogen and Progesterone Sales by Application (2027-2032) & (US$ Million) Table 59. Global Estrogen and Progesterone Sales Market Share in Value by Application (2027-2032) Table 60. Global Estrogen and Progesterone Price by Application (2027-2032) & (US$/Unit) Table 61. North America Estrogen and Progesterone Sales by Application (2021-2026) & (K Units) Table 62. North America Estrogen and Progesterone Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Estrogen and Progesterone Sales by Application (2021-2026) & (K Units) Table 64. Europe Estrogen and Progesterone Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Estrogen and Progesterone Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Estrogen and Progesterone Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Estrogen and Progesterone Sales by Application (2021-2026) & (K Units) Table 68. Latin America Estrogen and Progesterone Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Estrogen and Progesterone Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Estrogen and Progesterone Sales by Application (2021-2026) & (US$ Million) Table 71. Aspen Pharmacare Company Information Table 72. Aspen Pharmacare Business Overview Table 73. Aspen Pharmacare Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Aspen Pharmacare Estrogen and Progesterone Product Portfolio Table 75. Aspen Pharmacare Recent Development Table 76. Besins Healthcare Company Information Table 77. Besins Healthcare Business Overview Table 78. Besins Healthcare Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Besins Healthcare Estrogen and Progesterone Product Portfolio Table 80. Besins Healthcare Recent Development Table 81. Dr.Kade Pharmazeutische Fabrik Company Information Table 82. Dr.Kade Pharmazeutische Fabrik Business Overview Table 83. Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Product Portfolio Table 85. Dr.Kade Pharmazeutische Fabrik Recent Development Table 86. F.I.S.-FABBRICA Company Information Table 87. F.I.S.-FABBRICA Business Overview Table 88. F.I.S.-FABBRICA Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. F.I.S.-FABBRICA Estrogen and Progesterone Product Portfolio Table 90. F.I.S.-FABBRICA Recent Development Table 91. Gedeon Richter Company Information Table 92. Gedeon Richter Business Overview Table 93. Gedeon Richter Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Gedeon Richter Estrogen and Progesterone Product Portfolio Table 95. Gedeon Richter Recent Development Table 96. Jenapharm Company Information Table 97. Jenapharm Business Overview Table 98. Jenapharm Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Jenapharm Estrogen and Progesterone Product Portfolio Table 100. Jenapharm Recent Development Table 101. MERCK SERONO Company Information Table 102. MERCK SERONO Business Overview Table 103. MERCK SERONO Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. MERCK SERONO Estrogen and Progesterone Product Portfolio Table 105. MERCK SERONO Recent Development Table 106. N.V.Organon Company Information Table 107. N.V.Organon Business Overview Table 108. N.V.Organon Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. N.V.Organon Estrogen and Progesterone Product Portfolio Table 110. N.V.Organon Recent Development Table 111. Novartis Pharma Company Information Table 112. Novartis Pharma Business Overview Table 113. Novartis Pharma Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Novartis Pharma Estrogen and Progesterone Product Portfolio Table 115. Novartis Pharma Recent Development Table 116. Orion Company Information Table 117. Orion Business Overview Table 118. Orion Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Orion Estrogen and Progesterone Product Portfolio Table 120. Orion Recent Development Table 121. Pfizer Healthcare Company Information Table 122. Pfizer Healthcare Business Overview Table 123. Pfizer Healthcare Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Pfizer Healthcare Estrogen and Progesterone Product Portfolio Table 125. Pfizer Healthcare Recent Development Table 126. Teva Pharma Company Information Table 127. Teva Pharma Business Overview Table 128. Teva Pharma Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Teva Pharma Estrogen and Progesterone Product Portfolio Table 130. Teva Pharma Recent Development Table 131. AstraZeneca Company Information Table 132. AstraZeneca Business Overview Table 133. AstraZeneca Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. AstraZeneca Estrogen and Progesterone Product Portfolio Table 135. AstraZeneca Recent Development Table 136. Bayer Company Information Table 137. Bayer Business Overview Table 138. Bayer Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Bayer Estrogen and Progesterone Product Portfolio Table 140. Bayer Recent Development Table 141. Eli Lilly Company Information Table 142. Eli Lilly Business Overview Table 143. Eli Lilly Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Eli Lilly Estrogen and Progesterone Product Portfolio Table 145. Eli Lilly Recent Development Table 146. Novo Nordisk Company Information Table 147. Novo Nordisk Business Overview Table 148. Novo Nordisk Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Novo Nordisk Estrogen and Progesterone Product Portfolio Table 150. Novo Nordisk Recent Development Table 151. Abbott Company Information Table 152. Abbott Business Overview Table 153. Abbott Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Abbott Estrogen and Progesterone Product Portfolio Table 155. Abbott Recent Development Table 156. North America Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. North America Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 158. North America Estrogen and Progesterone Sales Market Share by Country (2021-2026) Table 159. North America Estrogen and Progesterone Sales Forecast by Country (2027-2032) & (K Units) Table 160. North America Estrogen and Progesterone Sales Market Share Forecast by Country (2027-2032) Table 161. North America Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Estrogen and Progesterone Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Estrogen and Progesterone Market Share by Country (2021-2026) Table 164. North America Estrogen and Progesterone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Estrogen and Progesterone Market Share Forecast by Country (2027-2032) Table 166. Europe Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Europe Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 168. Europe Estrogen and Progesterone Sales Market Share by Country (2021-2026) Table 169. Europe Estrogen and Progesterone Sales Forecast by Country (2027-2032) & (K Units) Table 170. Europe Estrogen and Progesterone Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Estrogen and Progesterone Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Estrogen and Progesterone Market Share by Country (2021-2026) Table 174. Europe Estrogen and Progesterone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Estrogen and Progesterone Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 178. Asia-Pacific Estrogen and Progesterone Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Estrogen and Progesterone Sales Forecast by Country (2027-2032) & (K Units) Table 180. Asia-Pacific Estrogen and Progesterone Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Estrogen and Progesterone Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Estrogen and Progesterone Market Share by Country (2021-2026) Table 184. Asia-Pacific Estrogen and Progesterone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Estrogen and Progesterone Market Share Forecast by Country (2027-2032) Table 186. Latin America Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Latin America Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 188. Latin America Estrogen and Progesterone Sales Market Share by Country (2021-2026) Table 189. Latin America Estrogen and Progesterone Sales Forecast by Country (2027-2032) & (K Units) Table 190. Latin America Estrogen and Progesterone Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Estrogen and Progesterone Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Estrogen and Progesterone Market Share by Country (2021-2026) Table 194. Latin America Estrogen and Progesterone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Estrogen and Progesterone Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 198. Middle East and Africa Estrogen and Progesterone Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Estrogen and Progesterone Sales Forecast by Country (2027-2032) & (K Units) Table 200. Middle East and Africa Estrogen and Progesterone Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Estrogen and Progesterone Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Estrogen and Progesterone Market Share by Country (2021-2026) Table 204. Middle East and Africa Estrogen and Progesterone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Estrogen and Progesterone Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Estrogen and Progesterone Distributors List Table 209. Estrogen and Progesterone Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Estrogen and Progesterone Image Figure 2. Global Estrogen and Progesterone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Estrogen and Progesterone Market Size (2021-2032) & (US$ Million) Figure 4. Global Estrogen and Progesterone Sales (2021-2032) & (K Units) Figure 5. Estrogen Image Figure 6. Global Estrogen Sales YoY Growth (2021-2032) & (K Units) Figure 7. Progesterone Image Figure 8. Global Progesterone Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Estrogen and Progesterone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Estrogen and Progesterone Market Share by Type 2025 VS 2032 Figure 11. North America Estrogen and Progesterone Sales Market Share in Volume by Type in 2025 Figure 12. North America Estrogen and Progesterone Sales Market Share in Value by Type in 2025 Figure 13. Europe Estrogen and Progesterone Sales Market Share in Volume by Type in 2025 Figure 14. Europe Estrogen and Progesterone Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Estrogen and Progesterone Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Estrogen and Progesterone Sales Market Share in Value by Type in 2025 Figure 17. Latin America Estrogen and Progesterone Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Estrogen and Progesterone Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Estrogen and Progesterone Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Estrogen and Progesterone Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Estrogen and Progesterone Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Department of Endocrinology Image Figure 28. Global Department of Endocrinology Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Estrogen and Progesterone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Estrogen and Progesterone Market Share by Application 2025 VS 2032 Figure 31. North America Estrogen and Progesterone Sales Market Share in Volume by Application in 2025 Figure 32. North America Estrogen and Progesterone Sales Market Share in Value by Application in 2025 Figure 33. Europe Estrogen and Progesterone Sales Market Share in Volume by Application in 2025 Figure 34. Europe Estrogen and Progesterone Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Estrogen and Progesterone Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Estrogen and Progesterone Sales Market Share in Value by Application in 2025 Figure 37. Latin America Estrogen and Progesterone Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Estrogen and Progesterone Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Estrogen and Progesterone Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Estrogen and Progesterone Sales Market Share in Value by Application in 2025 Figure 41. North America Estrogen and Progesterone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Estrogen and Progesterone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Estrogen and Progesterone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Estrogen and Progesterone Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Estrogen and Progesterone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Estrogen and Progesterone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Estrogen and Progesterone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Estrogen and Progesterone Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Estrogen and Progesterone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Estrogen and Progesterone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Estrogen and Progesterone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Estrogen and Progesterone Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Estrogen and Progesterone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Estrogen and Progesterone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Estrogen and Progesterone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Estrogen and Progesterone Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Estrogen and Progesterone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Estrogen and Progesterone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Estrogen and Progesterone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Estrogen and Progesterone Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Estrogen and Progesterone Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Estrogen and Progesterone Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Estrogen
  • Progesterone
Applications
  • Hospital
  • Pharmacy
  • Department of Endocrinology
Companies covered
  • Aspen Pharmacare
  • Besins Healthcare
  • Dr.Kade Pharmazeutische Fabrik
  • F.I.S.-FABBRICA
  • Gedeon Richter
  • Jenapharm
  • MERCK SERONO
  • N.V.Organon
  • Novartis Pharma
  • Orion
  • Pfizer Healthcare
  • Teva Pharma
  • AstraZeneca
  • Bayer
  • Eli Lilly
  • Novo Nordisk
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Estrogen and Progesterone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Estrogen and Progesterone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Estrogen and Progesterone Market by Type
  6. 1.3.1 Estrogen
  7. 1.3.2 Progesterone
  8. 1.4 Global Estrogen and Progesterone Market Size by Type
  9. 1.4.1 Global Estrogen and Progesterone Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Estrogen and Progesterone Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Estrogen and Progesterone Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Estrogen and Progesterone Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Estrogen and Progesterone Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Estrogen and Progesterone Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Estrogen and Progesterone Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Estrogen and Progesterone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Estrogen and Progesterone Industry Trends
  2. 2.2 Estrogen and Progesterone Industry Drivers
  3. 2.3 Estrogen and Progesterone Industry Opportunities and Challenges
  4. 2.4 Estrogen and Progesterone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Estrogen and Progesterone Revenue (2021-2026)
  2. 3.2 Global Top Players by Estrogen and Progesterone Sales (2021-2026)
  3. 3.3 Global Top Players by Estrogen and Progesterone Price (2021-2026)
  4. 3.4 Global Estrogen and Progesterone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Estrogen and Progesterone Major Company Production Sites & Headquarters
  6. 3.6 Global Estrogen and Progesterone Company, Product Type & Application
  7. 3.7 Global Estrogen and Progesterone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Estrogen and Progesterone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Estrogen and Progesterone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Estrogen and Progesterone Tier 1, Tier 2, and Tier 3
4 Estrogen and Progesterone Regional Status and Outlook
  1. 4.1 Global Estrogen and Progesterone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Estrogen and Progesterone Historic Market Size by Region
  3. 4.2.1 Global Estrogen and Progesterone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Estrogen and Progesterone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Estrogen and Progesterone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Estrogen and Progesterone Forecasted Market Size by Region
  7. 4.3.1 Global Estrogen and Progesterone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Estrogen and Progesterone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Estrogen and Progesterone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Estrogen and Progesterone by Application
  1. 5.1 Estrogen and Progesterone Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Department of Endocrinology
  5. 5.2 Global Estrogen and Progesterone Market Size by Application
  6. 5.2.1 Global Estrogen and Progesterone Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Estrogen and Progesterone Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Estrogen and Progesterone Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Estrogen and Progesterone Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Estrogen and Progesterone Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Estrogen and Progesterone Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Estrogen and Progesterone Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Estrogen and Progesterone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aspen Pharmacare
  2. 6.1.1 Aspen Pharmacare Company Information
  3. 6.1.2 Aspen Pharmacare Business Overview
  4. 6.1.3 Aspen Pharmacare Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aspen Pharmacare Estrogen and Progesterone Product Portfolio
  6. 6.1.5 Aspen Pharmacare Recent Developments
  7. 6.2 Besins Healthcare
  8. 6.2.1 Besins Healthcare Company Information
  9. 6.2.2 Besins Healthcare Business Overview
  10. 6.2.3 Besins Healthcare Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Besins Healthcare Estrogen and Progesterone Product Portfolio
  12. 6.2.5 Besins Healthcare Recent Developments
  13. 6.3 Dr.Kade Pharmazeutische Fabrik
  14. 6.3.1 Dr.Kade Pharmazeutische Fabrik Company Information
  15. 6.3.2 Dr.Kade Pharmazeutische Fabrik Business Overview
  16. 6.3.3 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Product Portfolio
  18. 6.3.5 Dr.Kade Pharmazeutische Fabrik Recent Developments
  19. 6.4 F.I.S.-FABBRICA
  20. 6.4.1 F.I.S.-FABBRICA Company Information
  21. 6.4.2 F.I.S.-FABBRICA Business Overview
  22. 6.4.3 F.I.S.-FABBRICA Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 F.I.S.-FABBRICA Estrogen and Progesterone Product Portfolio
  24. 6.4.5 F.I.S.-FABBRICA Recent Developments
  25. 6.5 Gedeon Richter
  26. 6.5.1 Gedeon Richter Company Information
  27. 6.5.2 Gedeon Richter Business Overview
  28. 6.5.3 Gedeon Richter Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Gedeon Richter Estrogen and Progesterone Product Portfolio
  30. 6.5.5 Gedeon Richter Recent Developments
  31. 6.6 Jenapharm
  32. 6.6.1 Jenapharm Company Information
  33. 6.6.2 Jenapharm Business Overview
  34. 6.6.3 Jenapharm Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jenapharm Estrogen and Progesterone Product Portfolio
  36. 6.6.5 Jenapharm Recent Developments
  37. 6.7 MERCK SERONO
  38. 6.7.1 MERCK SERONO Company Information
  39. 6.7.2 MERCK SERONO Business Overview
  40. 6.7.3 MERCK SERONO Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 MERCK SERONO Estrogen and Progesterone Product Portfolio
  42. 6.7.5 MERCK SERONO Recent Developments
  43. 6.8 N.V.Organon
  44. 6.8.1 N.V.Organon Company Information
  45. 6.8.2 N.V.Organon Business Overview
  46. 6.8.3 N.V.Organon Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 N.V.Organon Estrogen and Progesterone Product Portfolio
  48. 6.8.5 N.V.Organon Recent Developments
  49. 6.9 Novartis Pharma
  50. 6.9.1 Novartis Pharma Company Information
  51. 6.9.2 Novartis Pharma Business Overview
  52. 6.9.3 Novartis Pharma Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Pharma Estrogen and Progesterone Product Portfolio
  54. 6.9.5 Novartis Pharma Recent Developments
  55. 6.10 Orion
  56. 6.10.1 Orion Company Information
  57. 6.10.2 Orion Business Overview
  58. 6.10.3 Orion Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Orion Estrogen and Progesterone Product Portfolio
  60. 6.10.5 Orion Recent Developments
  61. 6.11 Pfizer Healthcare
  62. 6.11.1 Pfizer Healthcare Company Information
  63. 6.11.2 Pfizer Healthcare Business Overview
  64. 6.11.3 Pfizer Healthcare Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer Healthcare Estrogen and Progesterone Product Portfolio
  66. 6.11.5 Pfizer Healthcare Recent Developments
  67. 6.12 Teva Pharma
  68. 6.12.1 Teva Pharma Company Information
  69. 6.12.2 Teva Pharma Business Overview
  70. 6.12.3 Teva Pharma Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Teva Pharma Estrogen and Progesterone Product Portfolio
  72. 6.12.5 Teva Pharma Recent Developments
  73. 6.13 AstraZeneca
  74. 6.13.1 AstraZeneca Company Information
  75. 6.13.2 AstraZeneca Business Overview
  76. 6.13.3 AstraZeneca Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 AstraZeneca Estrogen and Progesterone Product Portfolio
  78. 6.13.5 AstraZeneca Recent Developments
  79. 6.14 Bayer
  80. 6.14.1 Bayer Company Information
  81. 6.14.2 Bayer Business Overview
  82. 6.14.3 Bayer Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bayer Estrogen and Progesterone Product Portfolio
  84. 6.14.5 Bayer Recent Developments
  85. 6.15 Eli Lilly
  86. 6.15.1 Eli Lilly Company Information
  87. 6.15.2 Eli Lilly Business Overview
  88. 6.15.3 Eli Lilly Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Eli Lilly Estrogen and Progesterone Product Portfolio
  90. 6.15.5 Eli Lilly Recent Developments
  91. 6.16 Novo Nordisk
  92. 6.16.1 Novo Nordisk Company Information
  93. 6.16.2 Novo Nordisk Business Overview
  94. 6.16.3 Novo Nordisk Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Novo Nordisk Estrogen and Progesterone Product Portfolio
  96. 6.16.5 Novo Nordisk Recent Developments
  97. 6.17 Abbott
  98. 6.17.1 Abbott Company Information
  99. 6.17.2 Abbott Business Overview
  100. 6.17.3 Abbott Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Abbott Estrogen and Progesterone Product Portfolio
  102. 6.17.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America Estrogen and Progesterone Sales by Country
  2. 7.1.1 North America Estrogen and Progesterone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Estrogen and Progesterone Sales by Country (2021-2026)
  4. 7.1.3 North America Estrogen and Progesterone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Estrogen and Progesterone Market Size by Country
  6. 7.2.1 North America Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Estrogen and Progesterone Market Size by Country (2021-2026)
  8. 7.2.3 North America Estrogen and Progesterone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Estrogen and Progesterone Sales by Country
  2. 8.1.1 Europe Estrogen and Progesterone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Estrogen and Progesterone Sales by Country (2021-2026)
  4. 8.1.3 Europe Estrogen and Progesterone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Estrogen and Progesterone Market Size by Country
  6. 8.2.1 Europe Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Estrogen and Progesterone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Estrogen and Progesterone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Estrogen and Progesterone Sales by Country
  2. 9.1.1 Asia-Pacific Estrogen and Progesterone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Estrogen and Progesterone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Estrogen and Progesterone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Estrogen and Progesterone Market Size by Country
  6. 9.2.1 Asia-Pacific Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Estrogen and Progesterone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Estrogen and Progesterone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Estrogen and Progesterone Sales by Country
  2. 10.1.1 South America Estrogen and Progesterone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Estrogen and Progesterone Sales by Country (2021-2026)
  4. 10.1.3 South America Estrogen and Progesterone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Estrogen and Progesterone Market Size by Country
  6. 10.2.1 South America Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Estrogen and Progesterone Market Size by Country (2021-2026)
  8. 10.2.3 South America Estrogen and Progesterone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Estrogen and Progesterone Sales by Country
  2. 11.1.1 Middle East and Africa Estrogen and Progesterone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Estrogen and Progesterone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Estrogen and Progesterone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Estrogen and Progesterone Market Size by Country
  6. 11.2.1 Middle East and Africa Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Estrogen and Progesterone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Estrogen and Progesterone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Estrogen and Progesterone Value Chain Analysis
  2. 12.1.1 Estrogen and Progesterone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Estrogen and Progesterone Production Mode & Process
  7. 12.2 Estrogen and Progesterone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Estrogen and Progesterone Distributors
  10. 12.2.3 Estrogen and Progesterone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst